Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
TWD 13.5
(-0.74%)
TWD 13.5
(-0.74%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 21.81 Million TWD | -39.04% |
| 2022 | 38.79 Million TWD | 150.69% |
| 2021 | -76.68 Million TWD | -135.52% |
| 2020 | -39.17 Million TWD | 75.01% |
| 2019 | -128.36 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 3.24 Million TWD | -84.81% |
| 2024 Q2 | 3.24 Million TWD | 197.75% |
| 2023 FY | - TWD | -39.04% |
| 2023 Q4 | 21.39 Million TWD | 0.0% |
| 2023 Q3 | 21.39 Million TWD | 317.55% |
| 2023 Q1 | -9.83 Million TWD | -392.58% |
| 2023 Q2 | -9.83 Million TWD | 0.0% |
| 2022 Q4 | 3.36 Million TWD | 0.0% |
| 2022 FY | - TWD | 150.69% |
| 2022 Q3 | 3.36 Million TWD | 0.0% |
| 2021 FY | - TWD | -135.52% |
| 2020 FY | - TWD | 75.01% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 94.459% |
| Level Biotechnology Inc. | 98.7 Million TWD | 77.904% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 148.749% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 130.243% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 186.434% |
| GlycoNex Incorporation | -126.82 Million TWD | 117.197% |
| VBI | -6.97 Million TWD | 412.823% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 115.178% |
| Visgeneer Inc. | 973 Thousand TWD | -2141.521% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 106.424% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 97.671% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 78.154% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 102.201% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 1355.613% |
| Enimmune corporation | -228.96 Million TWD | 109.526% |
| TaiRx, Inc. | -208.64 Million TWD | 110.453% |
| CHO Pharma, Inc. | -277.73 Million TWD | 107.853% |
| EirGenix Inc. | -664.4 Million TWD | 103.283% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 70.489% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 68.457% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 102.036% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 119.283% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 37.396% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 134.985% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 182.928% |
| RBC Bioscience Corporation | 36.54 Million TWD | 40.323% |
| BiOptic Inc. | 65.03 Million TWD | 66.466% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 103.196% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 166.079% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 139.716% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 94.97% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 147.163% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 223.04% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 121.049% |
| Neith Corporation | -33.61 Million TWD | 164.891% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 127.238% |
| NaviFUS Corp. | -55.79 Million TWD | 139.09% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 231.401% |
| Sinew Pharma Inc. | -163.63 Million TWD | 113.329% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 135.463% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 88.664% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 109.622% |
| AP Biosciences Inc | -325.51 Million TWD | 106.7% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 102.088% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 160.844% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 25.129% |
| Intech Biopharm Corporation | -219.58 Million TWD | 109.932% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 103.235% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 148.519% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 113.559% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 96.673% |
| TCI GENE Inc. | 25.98 Million TWD | 16.054% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 119.713% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 107.685% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 114.941% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -57.473% |
| PharmaEngine, Inc. | 347.3 Million TWD | 93.72% |
| Savior Lifetec Corporation | 219.6 Million TWD | 90.069% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 87.337% |
| OBI Pharma, Inc. | -855.08 Million TWD | 102.551% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 123.562% |
| Acepodia, Inc. | -764.51 Million TWD | 102.853% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 104.74% |